Theramex has announced that the Scottish Medicine Consortium (SMC) has recommended Yselty® for the treatment of moderate to severe symptoms of uterine fibroids (UFs) aligned to the product indication ...
The following is a summary of “Currently Available Treatment Modalities for Uterine Fibroids,” published in the May 2024 issue of Obstetrics & Gynecology by Micić et al. Uterine fibroids are common ...
Uterine fibroids are a common condition that affects up to 80% of women in their lifetime. Nearly half of those women will experience symptoms that affect their quality of life and fertility, ...
The prevalence of uterine fibroids in Japan affects approximately 10 million women, creating a substantial demand for effective treatment options. The country's medical facilities have performed over ...